结直肠癌共临床CT影像组学候选标志物管线的建立
本研究建立共临床CT影像组学管线,在RAS突变转移性结直肠癌原位异种移植模型中识别候选影像生物标志物。研究使用LOVO-Luc2和SW480-Luc2模型共104次肿瘤扫描及156次肝脏扫描,评估影像组学特征对治疗敏感性和早期转移的预测价值。结果显示纹理特征预测转移早于视觉CT评估,且部分特征在临床队列中与转移负荷和生存相关。
要点
- 肝脏纹理影像组学特征可在视觉CT评估之前预测转移(AUROC=0.871)
- 基线CT影像组学与LOVO-Luc2模型治疗敏感性相关(0.716)
- GLSZM灰度非均匀性等特征在临床队列中与转移负荷和生存显著相关
核心结论
- 临床前CT影像组学可识别与治疗敏感性和早期转移进展相关的定量影像特征
- 肝脏纹理影像组学特征预测转移早于视觉CT评估,AUROC达0.871
- 最具有预测价值的影像组学特征在临床CRC队列中与转移负荷和生存显著相关,提示跨物种保守性和转化价值
研究设计与样本
- 共临床研究设计,使用原位KRAS突变异种移植模型LOVO-Luc2(N=52)和SW480-Luc2(N=52)
- 模型接受标准治疗方案(FOLFOX、贝伐珠单抗或联合方案)并纵向CT成像,共收集104次肿瘤扫描和156次肝脏扫描,覆盖4个时间点
- 临床验证队列为CRC患者41例,用于评估影像组学特征与转移负荷和生存的关联
关键影像表现/征象
- 基线CT影像组学在LOVO-Luc2模型中识别治疗敏感性相关特征,相关性为0.716
- 一阶统计特征(Median、10percentile)与治疗结局显著相关
- 肝脏纹理影像组学特征可在视觉CT评估之前预测转移(AUROC=0.871)
- 最具预测价值的特征为GLSZM灰度非均匀性、GLRLM游程非均匀性归一化和GLDM小依赖性强调
诊断标准与关键数值
- 肝脏纹理影像组学预测转移的AUROC=0.871
- LOVO-Luc2模型中基线影像组学与治疗敏感性相关性为0.716
- 一阶统计特征Median和10percentile与治疗结局显著相关
- GLSZM灰度非均匀性、GLRLM游程非均匀性归一化、GLDM小依赖性强调与转移负荷和生存显著相关
临床应用与阅片要点
- 肝脏纹理影像组学特征可能早于肉眼CT评估提示微转移,可用于转移性结直肠癌的早期监测
- 基线肿瘤一阶统计特征(Median和10percentile)可能与RAS突变mCRC治疗敏感性相关,可作为疗效预测参考
- GLSZM和GLRLM纹理特征在临床队列中与转移负荷和生存相关,可作为预后相关候选标志物关注
局限性
- 临床验证队列样本量较小(N=41)
- 异种移植模型中的发现需在更大规模临床研究中进一步验证
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Here, we establish a co-clinical computed tomography (CT) radiomics pipeline for the identification of candidate imaging biomarkers in RAS-mutant metastatic colorectal cancer (mCRC). Orthotopic KRAS-mutant xenograft models (LOVO-Luc2 (N = 52) and SW480-Luc2 (N = 52)) were treated with standard-of-care regimens (FOLFOX, bevacizumab, or combination) and longitudinally imaged by CT (N = 104 tumour scans, N = 156 liver scans collected over 4 timepoints). Radiomic features derived from primary tumour and liver parenchyma were assessed as biomarkers of treatment sensitivity and early metastatic disease. Pre-treatment CT-radiomics identified baseline radiomic correlates of treatment sensitivity in the LOVO-Luc2 model (0.716), with first-order statistical features (Median, 10percentile) significantly associated with therapy outcome. Texture-based liver radiomic features enabled prediction of metastases earlier than visual CT assessment (AUROC = 0.871). The most predictive features, GLSZM Gray Level Non-Uniformity, GLRLM Run Length Non-Uniformity Normalized, and GLDM Small Dependence Emphasis, were significantly associated with metastatic burden and survival in a clinical CRC cohort (N = 41), indicating species conservation and translational relevance. Collectively, these data demonstrate that preclinical CT radiomics can identify quantitative imaging features associated with treatment sensitivity and early metastatic progression, supporting translational potential.
引用
- Connor, Prior, Shiels, et al. Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancer. Eur J Radiol. 2026. PMID: 42385277. doi:10.1016/j.ejrad.2026.113038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。